• 1
    French, A. R. and Yokoyama, W. M., Natural killer cells and viral infections. Curr. Opin. Immunol. 2003. 15: 4551.
  • 2
    VanDeusen, J. B. and Caligiuri, M. A., New developments in anti-tumor efficacy and malignant transformation of human naturalkiller cells. Curr. Opin. Hematol. 2003. 10: 5559.
  • 3
    Zitvogel, L., Dendritic and natural killer cells cooperate in the control/switch of innate immunity. J. Exp. Med. 2002. 195: F914.
  • 4
    Valiante, N. M., Uhrberg, M., Shilling, H. G., Lienert-Weidenbach, K., Arnett, K. L., D'Andrea, A., Phillips, J. H., Lanier, L. L. and Parham,P., Functionally and structurally distinct NK cell receptor repertoires in the peripheral blood of two human donors. Immunity 1997. 7: 739751.
  • 5
    Dohring, C., Scheidegger, D., Samaridis, J., Cella, M. and Colonna, M., A human killer inhibitory receptor specific for HLA-A1,2. J. Immunol. 1996. 156: 30983101.
  • 6
    Pende, D., Biassoni, R., Cantoni, C., Verdiani, S., Falco, M., di Donato, C., Accame, L., Bottino, C., Moretta, A. and Moretta, L., The natural killer cell receptor specific for HLA-A allotypes: a novel member of the p58/p70 family of inhibitory receptors that is characterized by three immunoglobulin-like domains and is expressed as a 140-kD disulphide-linked dimer. J. Exp. Med. 1996. 184: 505518.
  • 7
    Hill, A. B., Lee, S. P., Haurum, J. S., Murray, N., Yao, Q. Y., Rowe, M., Signoret, N., Rickinson, A. B. and McMichael, A. J., Class I major histocompatibility complex-restricted cytotoxic T lymphocytes specific for Epstein-Barr virus (EBV)-transformed B lymphoblastoid cell lines against which they were raised. J. Exp. Med. 1995. 181: 22212228.
  • 8
    DiBrino, M., Parker, K. C., Shiloach, J., Knierman, M., Lukszo, J., Turner, R. V., Biddison, W. E. and Coligan, J. E., Endogenous peptides bound to HLA-A3possess a specific combination of anchor residues that permit identification of potential antigenic peptides. Proc. Natl. Acad. Sci. USA 1993. 90: 15081512.
  • 9
    Sidney, J., Grey, H. M., Kubo, R. T. and Sette, A., Practical, biochemical and evolutionary implications of the discovery of HLA class I supermotifs. Immunol. Today 1996. 17: 261266.
  • 10
    Peruzzi, M., Parker, K. C., Long, E. O. and Malnati, M. S., Peptidesequence requirements for the recognition of HLA-B*2705 by specific natural killer cells. J. Immunol. 1996. 157: 33503356.
  • 11
    Rajagopalan, S. and Long, E. O., The direct binding of a p58 killer cell inhibitory receptor to human histocompatibility leukocyte antigen (HLA)-Cw4 exhibits peptide selectivity. J. Exp. Med. 1997. 185: 15231528.
  • 12
    Mandelboim, O., Wilson, S. B., Vales-Gomez, M., Reyburn, H. T. and Strominger, J. L., Self and viral peptides can initiate lysis by autologous natural killer cells. Proc. Natl. Acad. Sci. USA 1997. 94: 46044609.
  • 13
    Boyington, J. C., Motyka, S. A., Schuck, P., Brooks, A. G. and Sun, P. D., Crystal structure of an NK cell immunoglobulin-like receptor in complex with its class I MHC ligand. Nature 2000. 405: 537543.
  • 14
    Boyington, J. C., Brooks, A. G. and Sun, P. D., Structure of killer cell immunoglobulin-like receptors and their recognition of the class I MHC molecules. Immunol. Rev. 2001. 181: 6678.
  • 15
    Malnati, M. S., Peruzzi, M., Parker, K. C., Biddison, W. E., Ciccone, E., Moretta, A. and Long, E. O., Peptide specificity in the recognition of MHC class I by natural killer cell clones. Science 1995. 267: 10161018.
  • 16
    Zappacosta, F., Borrego, F., Brooks, A. G., Parker, K. C. and Coligan, J. E., Peptides isolated from HLA-Cw*0304 confer different degrees of protection from natural killer cell-mediated lysis. Proc. Natl. Acad. Sci. USA 1997. 94: 63136318.
  • 17
    Khakoo, S. I., Geller, R., Shin, S., Jenkins, J. A. and Parham, P., The D0 domain of KIR3D acts as a major histocompatibility complex class I binding enhancer. J. Exp. Med. 2002. 196: 911921.
  • 18
    Gardiner, C. M., Guethlein, L. A., Shilling, H. G., Pando, M., Carr, W. H., Rajalingam, R., Vilches, C. and Parham, P., Different NK cell surface phenotypes defined by the DX9 antibody are due to KIR3DL1 gene polymorphism. J. Immunol. 2001. 166: 29923001.
  • 19
    Bagot, M., Moretta, A., Sivori, S., Biassoni, R., Cantoni, C., Bottino, C., Boumsell, L. and Bensussan, A., CD4(+) cutaneous T cell lymphoma cells express the p140-killer cell immunoglobulin-like receptor. Blood 2001. 97: 13881391.
  • 20
    Wechsler, J., Bagot, M., Nikolova, M., Parolini, S., Martin-Garcia, N., Boumsell, L., Moretta, A. and Bensussan, A., Killer cell immunoglobulin-like receptor expression delineates in situ Sezary syndrome lymphocytes. J. Pathol. 2003. 199: 7783.
  • 21
    Allan, D. S., Colonna, M., Lanier, L. L., Churakova, T. D., Abrams, J. S., Ellis, S. A., McMichael, A. J. and Braud, V. M., Tetrameric complexes of humanhistocompatibility leukocyte antigen (HLA)-G bind to peripheral blood myelomonocytic cells. J. Exp. Med. 1999. 189: 11491156.
  • 22
    Kollnberger, S., Bird, L., Sun, M. Y., Retiere, C., Braud, V. M., McMichael, A. and Bowness, P., Cell-surface expression and immune receptor recognition of HLA-B27 homodimers. Arthritis Rheum. 2002. 46: 29722982.
  • 23
    Lanier, L. L., Corliss, B., Wu, J. and Phillips, J. H., Associationof DAP12 with activating CD94/NKG2C NK cell receptors. Immunity 1998. 8: 693701.
  • 24
    Pulford, K., Micklem, K., Thomas, J., Jones, M. and Mason, D. Y., A 72-kD B cell-associated surface glycoprotein expressed at high levels in hairy cell leukaemia and plasma cell neoplasms. Clin. Exp. Immunol. 1991. 85: 429435.
  • 25
    Altman, J. D., Moss, P. A., Goulder, P. J., Barouch, D. H., McHeyzer-Williams, M. G., Bell, J. I., McMichael, A. J. and Davis, M. M., Phenotypic analysisof antigen-specific T lymphocytes. Science 1996. 274: 9496.
  • 26
    Appay, V. and Rowland-Jones, S. L., The assessment of antigen-specific CD8+ T cells through the combination of MHC class I tetramer and intracellular staining. J. Immunol. Methods 2002. 268: 919.